Eileen Scully, MD, PhD

CRS:

JHU

Role:

Investigators

Position:

Investigator

Email:

escully1@jhmi.edu

Dr. Eileen Scully is an assistant professor of medicine at the Johns Hopkins University School of Medicine. 

She received her B.S. from the University of Notre Dame. She earned her Ph.D. and M.D. from Yale University. She completed her residency at Brigham and Women’s Hospital and performed a fellowship in infectious diseases at Massachusetts General Hospital.

  • Protocol Chair, ACTG A5366
  • Investigator, Women's Health Inter-Network Scientific Committee (Dec 2017-Nov 2019)

Categories

Leadership Committees
CRS
Roles

Clinical Trials

HPTN 069: A Phase II Randomized, Double-Blind, Study of the...

HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...

Read More

A5207, Maintaining Options for Mothers Study (MOMS): A Phase...

A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...

Read More

A5288: MULTIOCTAVE, Management Using the Latest Technologies...

The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...

Read More

IMPAACT 2034 - Phase I Study of the Pharmacokinetics,...

This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...

Read More

P2010: Phase III Study of the Virologic Efficacy and Safety...

IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...

Read More